FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to obstetrics, pathological physiology, and can be used to predict placental insufficiency in the third trimester in women with moderate course of COVID-19 in the first trimester of pregnancy. Percentage of TNFR1 and VEGFR2 on peripheral blood monocytes is determined by flow cytofluorometry. Established diagnostic values are used to determine the prognosis of developing placental insufficiency in the third trimester in women with moderate course of COVID-19 in the first trimester of pregnancy. If the value of TNFR1 is equal to or more than 86.95%, and VEGFR2 is equal to or less than 21.72%, developing placental insufficiency in the third trimester is predicted in women with moderate course of COVID-19 in the first trimester of pregnancy.
EFFECT: method provides the possibility of increasing the accuracy of prediction of placental insufficiency in the third trimester in women with moderate course of COVID-19 in the first trimester, due to the fact that in pregnant women with moderate course of COVID-19 in the first trimester, percentage of TNFR1 and VEGFR2 on peripheral blood monocytes is determined by flow cytofluorometry.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PLACENTAL INSUFFICIENCY IN THIRD TRIMESTER OF PREGNANCY IN WOMEN WITH MODERATE COURSE OF COVID-19 | 2024 |
|
RU2828539C1 |
| METHOD OF PREDICTING PRETERM LABOR IN WOMEN WITH PNEUMONIA IN THE THIRD TRIMESTER CAUSED BY SARS-CoV-2 | 2023 |
|
RU2801031C1 |
| METHOD FOR PREDICTION OF THREATENED MISCARRIAGE BY DETERMINING BLOOD SERUM OF 8-ISOPROSTANE AND 15-HYDROXYEICOSATETRAENOIC ACID IN WOMEN WITH COVID-19 IN THE FIRST TRIMESTER | 2024 |
|
RU2821133C1 |
| METHOD FOR PREDICTION OF PREMATURE BIRTH BY MEASURING BLOOD SERUM OF 8-ISOPROSTANE AND 12-HYDROXYEICOSATETRAENOIC ACID IN PREGNANT WOMEN WITH COVID-19 IN THE THIRD TRIMESTER | 2024 |
|
RU2821128C1 |
| METHOD FOR PREDICTING ANEMIA IN PREGNANT WOMEN WITH COVID-19 PNEUMONIA | 2022 |
|
RU2772906C1 |
| METHOD FOR ASSESSING RISK OF PERINATAL COMPLICATIONS ASSOCIATED WITH INFECTION CAUSED BY SARS-COV-2 IN THIRD TRIMESTER OF PREGNANCY | 2023 |
|
RU2820005C1 |
| METHOD FOR PREDICTION OF PLACENTAL INSUFFICIENCY IN SECOND HALF OF PREGNANCY IN SEROPOSITIVE BY CYTOMEGALOVIRUS WOMEN | 2020 |
|
RU2724395C1 |
| METHOD FOR PREDICTION OF SPONTANEOUS MISCARRIAGE AFTER SUFFERING NEW CORONAVIRUS INFECTION (NCOV) OF MILD AND MODERATE FORM | 2024 |
|
RU2816804C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING A SEVERE COURSE OF CORONAVIRUS INFECTION IN WOMEN | 2021 |
|
RU2761138C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING A SEVERE COURSE OF CoVID-19 | 2022 |
|
RU2782796C1 |
